drugset
drugset / Trial / NCT05592262

Pharmacokinetic Test of High-fat Diet After Oral Administration of SHR2554 in Healthy Subjects

NCT05592262 ↗

Phase 1 Completed 20 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of the study is to assess the effect of food on the pharmacokinetics, and safety of SHR2554 Tablets in healthy subjects.

Timeline

Start
2022-11-15
Primary completion
2022-12-14
Completion
2022-12-14

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR2554 Small molecule — —

Indications

cancer